IFNA1 and COVID-19: We next aimed to characterize the clinical phenotype of IFN-neutralizing AAB-positive COVID-19 patients in the CSC at hospital admission and to identify discriminatory markers that may serve as pre-selection criteria for their early identification and stratification.